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Since the development of the ruby
laser by Maiman in 1959, two major
questions have been raised with regard
to ophthalmology:
1. What is the feasibility for its
clinical use as a therapeutic device?
2. What are the hazards of accidental exposures among personnel
working with lasers in industry, research, and military installations;
how to counteract them?
After clinical light coagulation for
various ocular lesions had been included in the therapeutic armamentarium, the introduction of the laser
for similar purposes was obvious, and
has been accepted with enthusiasm by
various groups of clinical investigators. Since, at present, the ruby laser
is only used for ophthalmological purposes, the basic principles of its action
are briefly reviewed.
Fundamentals of Laser Action

When a photon is absorbed by an
atom, the energy of the photon is
converted to internal energy of the
atom. The atom is then raised to an
"excited" quantum state. Later it may
radiate this energy spontaneously,
emitting a photon and reverting to the
ground state or to some state in between.
In such an excited state the atom
can be stimulated to emit a photon, if
it is struck by another photon having
precisely the energy of the one that
would otherwise be emitted spontaneously. As a result, the incoming photon, or wave, is augmented by the one
given up by the excited atom. More
important, the wave, upon release,
falls precisely in phase with the wave
that triggered its release. There must

be an excess of excited atoms to enable stimulated emission to predominate over absorption.
In the ruby laser (aluminum oxide
poisoned with a few chromium atoms
-Maiman used .05% by wt of chromium), light in the green and yellow
bands is absorbed, while blue and red
are allowed to pass through. The absorbed light raises the chromium atoms
to the excited state from which two
steps are required to carry them back
to the ground state.
First, they give up some of their
energy to the crystal lattice and land
temporarily in a metastable state. If
not subjected to stimulation, their stay
at this level lasts a few msec while
they drop at random to the ground
state.
Photons emitted during this final
drop have a wavelength of 6,943 A
(at room temperature). In the laser,
however, the first few photons released stimulate the still excited chromium atoms to give· up photons and
return to the ground state much faster.
If a great number of atoms are excited, the ruby merely emits a burst
of its typical red fluorescence, spread
over the usual decay period for the
excited atoms. But above a critical
level, in which more than 50% of the
total atoms are brought in the excited
state, the atoms return to the ground
state at the very same moment. They
last approximately 200 to 500 µsec,
during which time an intense monochromatic light beam flashes from the
laser crystal. The beam is almost parallel if produced at threshold levels.
With greater energies increasing divergence occurs.
From the foregoing it becomes obvious that the characteristics of laser
radiation are different in several as17
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pects from the clinical light coagulator
used before. The most important differences are:
1) The spectral distribution of the
light source, and
2) The exposure time for production of chorioretinal "burns."
While the conventional Zeiss light
coagulator utilizes a xenon high pressure lamp with a spectral range
throughout the visible spectrum, the
ruby laser beam is monochromatic and
produces light at a wavelength of
6,943 A only. Moreover, the light coagulator allows the ophthalmologist to
control the exposure time by pressing
a button situated on the ophthalmoscope handle; thus the exposure time
is determined under direct vision of
the developing tissue response. On the
other hand, the exposure time with the
use of the laser is inherent within the
instrument, and is not controllable
during the exposure. Thus, while the
light coagulator exposures usually
range from about 0.1 sec to 1 sec, ruby
laser exposure times are in the neighborhood of 500 µ,sec .
These two factors-wavelength and
exposure time-however, are of fundamental importance with regard to
tissue reaction. During recent years
absorption characteristics of the human and the rabbit eye have been
studied, especially with respect to absorption distribution in the pigmented
layers of the ocular fundus. The data
were compared with reflection measurements from the ocular fundus, and
with light energies required to produce
ophthalmoscopic visible minimal lesions. Moreover, the influence of blood
flow on the development of ocular
thermal effect has been investigated.
More recently, a histological and histochemical comparison of ocular lesions produced with light coagulation
with those produced with a ruby laser
has been described. In later studies
exposure times for light coagulation
were 30 msec and 175 µ,sec, while
laser exposures were achieved with
200 µ,sec for "pulsed" and 30 µ,sec .
for "q-switched" laser action (Geeraets"
et al., 1960, 1962a and b, 1963, and
1965; Ham et al., 1963).
Clinical Considerations

Initial Promise and Present Limitations
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The Zeiss light coagulator has been
used for over a decade to treat such
ocular lesions as retinal detachment,
vascular lesions of the retina and
choroid, inflammatory chorioretinal
conditions, iris lesions, etc. As soon as
the laser was introduced, several of its
features seemed more advantageous
relative to this conventional light coagulator:
1) The price of the instrument was
expected to be considerably lower than
that of the Zeiss light coagulator.
2) The instrument promised to be
quite light so that it could easily be
carried to the patient's bedside, instead
of having to bring the patient to the
instrument.
3) The very short exposure times
wae regarded as beneficial, since with
these exposure times the patient would
not be able to move his eye, thus eliminating the need for retrobulbar anesthesia.
4) The dim red light of the laser
beam (A.
6,943 A) will not produce
photophobia, another reason for eliminating anesthesia.
5) The short-time, high-intensity exposures would allow much smaller lesions than those produced by light coagulation.
However, after several years of
clinical and laboratory experimentation, these anticipated advantages appear at present not as obvious or as
convincing as a number of investigators had initially expected. Moreover,
it is quite certain today that the laser
has not broadened clinical indications
nor has it opened new fields for therapeutic application of high intensity
light.
Several instruments utilizing the
pulsed ruby laser are now commercially available. With the desire to develop a therapeutic device having as
many safeguards as possible against
possible overexposures, the price and
weight of the instruments have both increased and are still rising; thus the expected advantages outlined above
under 1) and 2) seem not to be warranted. It is true, however, that the
short exposure time and the dim red
light do not necessitate retrobulbar
anesthesia of the patient's eye. This
minor advantage is contradicted by the
dangers of short-time exposures. When
the instrument is triggered, the degree
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and severity of the chorioretinal lesion
is decided upon. Even if the surgeon
has followed instructions and started
with low instrument settings-Le., low
energy output which does not cause
any lesions-and has slowly increased
the laser beam intensity, the exposures
are not without danger. The energy
output of the laser varies from shot to
shot in a random fashion unless special
precautions are taken. Moreover, the
energy control settings of the instruments have only a very small range
between therapeutically desirable intensities, and those which will produce
severe overexposures. With this narrow range, and the possible fluctuations from one exposure to another,
the usefulness of the instruments presently available is limited. Beside these
inherent limitations, the irregularities
in pigment distribution of the ocular
fundus add to the potential hazards
which might be encountered. Examination of a number of eyes treated
elsewhere with lasers, for various etiological reasons, revealed lesions which
were too severe and well above optimal therapeutic levels. Many of the
lesions showed centrally located retinal holes with small hemorrhages and
pigment clumps extending into the
vitreous.
There may be an advantage in producing chorioretinal coagulations with
very short exposure times when the
exposure has to be made in a region
where injury to the nerve fiber layer
may result in a large scotoma. Here,
the short exposure times allow for the
coagulation effect to be restricted to
the choroid and outer retinal layers,
thus sparing the inner layers of the
retina and the nerve fibers passing
over the lesion. This observation, made
in numerous experiments (Geeraets,
Burkhart, and Guerry, 1963), can be
explained by the absence of tissue
damage due to thermal conduction
during actual exposure time, if the exposure times are sufficiently short, i.e.,
in µ,sec . The lesions thus produced
must be very mild as heat conduction,
continuing from the site of coagulation
after the exposure has terminated,
might be sufficient to cause coagulation of all retinal layers.
The statement that smaller retinal
lesions can be produced with a laser is
true, but is of little clinical impor-
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tance. I have never observed a clinical
situation in which a lesion smaller
than that producible with the common
light coagulator was desired.
Use in Retinal Tumors

Retinal tumors have been mentioned as another indication for laser
treatment. Here, too, the same rules
can be applied that have been established for treatment of tumors with
light coagulation. One might even
speculate that the more extensive coagulation effect using common light
coagulation techniques may be more
destructive to tumor cells than the
laser beam. But the very restricted indications for coagulation treatment of
ocular neoplasm remains the same for
both methods.
Experimental data obtained on tumor transplants within the suprachoroidal space have shown some of the
restrictions one has to observe in such
attempts of treatment (Geeraets,
Ghosh, and Guerry, 1962; Chan et al.,
1963). In cases of retinal angiomata,
the red light of the ruby is reflected
to a great extent, thus unnecessarily
increasing the incident total light
energy applied to the ocular media
and other ocular structures.
Accidental Laser Exposures

With the very powerful devices developed for industrial, military, and
research use, accidental exposures of
the human retina have presented a
true hazard. Not only the direct exposure to the laser beam, but also laser
light from any reflecting surface may
result in permanent ocular injury.
Since light of the ruby laser (.\. =
6,943 A) is dim red, and light from
the neodymium laser (.\.
1,060 A) is
completely outside the visible spectrum, the potential hazard to the eye
is greatly enhanced as no immediate
discomfort is experienced by the victim. If the ocular lesion is mild and
located in the peripher)' of the retina,
the victim may not even be aware of
the accident. I have seen such lesions
on routine examination where there
was no doubt as to the etiology of the
lesion. If exposures occur to the fovea
or macular area, as in cases where the
patient is "fixing" the laser source

=

along the axis of the laser beam or a
reflecting spot, the lesion may be of
serious consequence, even with mild
retinal lesions. And if both eyes are
involved, which most likely will happen if the patient is "fixing" on the
bright light, the developing macular
lesions may produce permanent visual
loss.
In case of high-intensity exposures,
for instance, as with the giant pulse
laser, central as well as peripheral
fundus lesions may lead to an explosion-like disruption of the retina and
choroid, with massive hemorrhages
into the vitreous, resulting in permanent loss of one or both eyes.
These accidental possibilities have
necessitated extensive precautions in
most installations and laboratories
where laser devices are used. Warning
signs have been placed in most locations during actual laser operation.
Laboratory facilities and equipment
have been painted with dark and dull
colors to reduce reflection. Special
goggles with hardened lenses and color
filters have been developed for eye
protection. But in spite of these precautions, accidental exposures are not
infrequent. Bright flashes of white
light produce photophobia and hence
constantly bring the danger of exposure to the persons working with these
light sources. With the dark red laser
beam or the invisible neodymium
beam this reminder is absent, possibly
explaining the observed negligence by
laboratory personnel involved. For
legal reasons it has been recommended
that any prospective employee to work
with, or in the vicinity of, laser devices be given a very thorough eye
examination by a qualified ophthalmologist to record all possible existing
fundus pathology or anomalies before
the person begins work. Routine follow-up examinations should be performed within reasonable periods to
insure that no accidental fundus exposures have occurred without the
person's knowledge. All reported possible exposures should get immediate
medical attention, since laser lesions
are more accurately determined the
sooner they are examined after exposure. After longer periods of time, scar
formation may not be differentiated
from other preexisting inflammatory
lesions.
19

LASER IN OPHTHALMIC PRACTICE
According to Tebrock, Young, and
Machle (1963), the principles of controlling environmental laser hazards
are:
1) Avoidance of the principal beam
and its reflections.
2) Proper education of personnel
involved.
3) General information given those
who might be casually exposed.
4) Use of warning devices to indicate laser is in operation.
5) Policing and clearing of area for
long range operation.
6) Use of proper antilaser eye
shields on any observer likely to be
exposed.
7) Use of count-downs with persons closing eyes or looking away
from pulsed, high-power beam.
8) Reporting of all persistent afterimages to medical department.
9) Funduscopic and slit-lamp examination of all people involved in
laser operations.
Conclusions

In spite of the limitations and potential hazards involved in ophthalmic
application of laser energy at its present status of development, further
clinical investigation is necessary. It
should be restricted to a few centers,
experienced in this type of work, and
aware of the fundamental physical and
biological mechanisms involved. In
reality, this practice is not always followed, thus increasing the potential
danger of the clinical use of lasers.
Although some of the available instruments are beautifully designed and
engineered, these attributes alone do
not justify their therapeutic use. In my
opinion, arrangements to make the
present existing laser coagulators commercially available to all clinical ophthalmologists are irresponsible, to say
the least. Some of the ophthalmologists are misled by erroneous advertisement and receive their instruction
from overzealous sales personnel lacking adequate knowledge of the physical principles of laser, or of the
biological, optical, and functional
characteristics of the eye.
Summary

The present status of laser appli20

cation in clinical ophthalmology is
discussed. The differences between
conventional light coagulator characteristics and those of presently available ruby lasers for clinical use are
compared. The limitations and hazards of laser therapy are stressed.
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